The US Supreme Court’s decision striking down Purdue Pharma’s bankruptcy settlement is creating significant reverberations throughout the legal system. In a closely-watched ruling, the Court found that liability releases for members of the billionaire Sackler family, who owned Purdue, were illegal because they were granted without the consent of some plaintiffs who had filed lawsuits over the family’s opioid sales tactics. This marks a pivotal moment in bankruptcy law, as litigators and judges explore the implications of the decision and its boundaries.
Already, legal professionals are taking swift action. According to the ruling, courts have approved temporary pauses on litigation cases post the Purdue decision. This pause gives courts an opportunity to grapple with and better understand how the decision affects current bankruptcy protections and shields, leaving certain litigation avenues vulnerable.
The Supreme Court’s decision in Harrington v. Purdue Pharma has the potential to reshape strategies used by bankruptcy attorneys. With this new framework, courts and lawyers must navigate a challenging landscape where prior assumptions about the legality of certain protections are no longer secure. The rejection of these liability releases marks a significant shift in how future settlements may be approached, signaling a need for consent from all litigants when such protections are sought.
For legal professionals and corporate counsels, this ruling necessitates a reevaluation of current cases and may lead to more cautious approaches in drafting future bankruptcy settlements. The decision is slowly but surely reshaping the field, leaving an indelible impact on how bankruptcy law will be interpreted and applied moving forward.